From Multi-Checkpoint Blockade to Coordinated Tumor-Immune Reprogramming
Editor’s Note: From Innovation to a Partner-Ready Asset Welcome to Global Innovation Asset Insight, a
Interpretation of China’s Pharmaceutical Patent Term Compensation (PTE) System
From patent application to final approval and marketing, a new drug often takes more than
China’s innovative drug exports accelerate again—this year, overseas licensing exceeded $120 billion
On September 14, the launch ceremony of the 2026 "National Drug Safety Publicity Week" was
Key points for drafting drug formulation patents
Drug formulation patents are a key link connecting APIs with clinical applications. A compound patent
Intellectual Property Newsletter by MeritsIP, September 14, 2026
Editor's Note: Intellectual Property Highlights and Strategies for Innovation Welcome to the MeritsIP Newsletter. We
Key points in patent layout for small nucleotide drugs (siRNA).
siRNA drugs have become one of the fastest-growing innovative therapies in the biopharmaceutical field in
Co-Co, NewCo, and Early Overseas Expansion: Three New Paths for Chinese Innovative Drugs Going Global
Opening Introduction: In the first half of 2026, the total overseas licensing transaction volume of
Intellectual Property Newsletter by MeritsIP, September 07, 2026
Editor's Note: Intellectual Property Highlights and Strategies for Innovation Welcome to the MeritsIP Newsletter. We
From Purinergic Inflammation Biology to an Oral IBD Medicine: The Global P2Y14 Receptor Antagonist Landscape
Editor’s Note: From Innovation to a Partner-Ready Asset Welcome to Global Innovation Asset Watch, a
From Dual Targeting to Multi-Mechanism Tumor Control: The Global Bispecific and Dual-Payload ADC Landscape
Editor’s Note: From Innovation to a Partner-Ready Asset Welcome to Global Innovation Asset Watch, a
From Reactive Toxicity Management to Built-In Cytokine Control: The Global Safety-Engineered CD19 CAR-T Landscape
Editor’s Note: From Innovation to a Partner-Ready Asset Welcome to Global Innovation Asset Watch, a
From Broad Immunomodulation to a Reproducible Cell Medicine: The Global Off-the-Shelf UC-MSC Therapeutics Landscape
Editor’s Note: From Innovation to a Partner-Ready Asset Welcome to Global Innovation Asset Watch, a